262 related articles for article (PubMed ID: 17705204)
1. Saccharin inhibits carbonic anhydrases: possible explanation for its unpleasant metallic aftertaste.
Köhler K; Hillebrecht A; Schulze Wischeler J; Innocenti A; Heine A; Supuran CT; Klebe G
Angew Chem Int Ed Engl; 2007; 46(40):7697-9. PubMed ID: 17705204
[No Abstract] [Full Text] [Related]
2. X-ray crystallographic and kinetic investigations of 6-sulfamoyl-saccharin as a carbonic anhydrase inhibitor.
Alterio V; Tanc M; Ivanova J; Zalubovskis R; Vozny I; Monti SM; Di Fiore A; De Simone G; Supuran CT
Org Biomol Chem; 2015 Apr; 13(13):4064-9. PubMed ID: 25733161
[TBL] [Abstract][Full Text] [Related]
3. Saccharin sulfonamides as inhibitors of carbonic anhydrases I, II, VII, XII, and XIII.
Morkūnaitė V; Baranauskienė L; Zubrienė A; Kairys V; Ivanova J; Trapencieris P; Matulis D
Biomed Res Int; 2014; 2014():638902. PubMed ID: 25276805
[TBL] [Abstract][Full Text] [Related]
4. Multiple binding modes of inhibitors to carbonic anhydrases: how to design specific drugs targeting 15 different isoforms?
Alterio V; Di Fiore A; D'Ambrosio K; Supuran CT; De Simone G
Chem Rev; 2012 Aug; 112(8):4421-68. PubMed ID: 22607219
[No Abstract] [Full Text] [Related]
5. Saccharin: a lead compound for structure-based drug design of carbonic anhydrase IX inhibitors.
Mahon BP; Hendon AM; Driscoll JM; Rankin GM; Poulsen SA; Supuran CT; McKenna R
Bioorg Med Chem; 2015 Feb; 23(4):849-54. PubMed ID: 25614109
[TBL] [Abstract][Full Text] [Related]
6. Indanesulfonamides as carbonic anhydrase inhibitors. Toward structure-based design of selective inhibitors of the tumor-associated isozyme CA IX.
Thiry A; Ledecq M; Cecchi A; Dogné JM; Wouters J; Supuran CT; Masereel B
J Med Chem; 2006 May; 49(9):2743-9. PubMed ID: 16640335
[TBL] [Abstract][Full Text] [Related]
7. Carbonic anhydrase inhibitors. Interaction of 2-N,N-dimethylamino-1,3,4-thiadiazole-5-methanesulfonamide with 12 mammalian isoforms: kinetic and X-ray crystallographic studies.
Temperini C; Cecchi A; Boyle NA; Scozzafava A; Cabeza JE; Wentworth P; Blackburn GM; Supuran CT
Bioorg Med Chem Lett; 2008 Feb; 18(3):999-1005. PubMed ID: 18162396
[TBL] [Abstract][Full Text] [Related]
8. Inhibition and catalysis of carbonic anhydrase. Recent crystallographic analyses.
Liljas A; Håkansson K; Jonsson BH; Xue Y
Eur J Biochem; 1994 Jan; 219(1-2):1-10. PubMed ID: 8306976
[No Abstract] [Full Text] [Related]
9. Carbonic anhydrase inhibitors. Interaction of 2-(hydrazinocarbonyl)-3-phenyl-1H-indole-5-sulfonamide with 12 mammalian isoforms: kinetic and X-ray crystallographic studies.
Güzel O; Temperini C; Innocenti A; Scozzafava A; Salman A; Supuran CT
Bioorg Med Chem Lett; 2008 Jan; 18(1):152-8. PubMed ID: 18024029
[TBL] [Abstract][Full Text] [Related]
10. A Combined Crystallographic and Theoretical Study Explains the Capability of Carboxylic Acids to Adopt Multiple Binding Modes in the Active Site of Carbonic Anhydrases.
Langella E; D'Ambrosio K; D'Ascenzio M; Carradori S; Monti SM; Supuran CT; De Simone G
Chemistry; 2016 Jan; 22(1):97-100. PubMed ID: 26507456
[TBL] [Abstract][Full Text] [Related]
11. Homology modeling and receptor-based 3D-QSAR study of carbonic anhydrase IX.
Tuccinardi T; Ortore G; Rossello A; Supuran CT; Martinelli A
J Chem Inf Model; 2007; 47(6):2253-62. PubMed ID: 17949069
[TBL] [Abstract][Full Text] [Related]
12. X-ray crystallography-promoted drug design of carbonic anhydrase inhibitors.
Ivanova J; Leitans J; Tanc M; Kazaks A; Zalubovskis R; Supuran CT; Tars K
Chem Commun (Camb); 2015 Apr; 51(33):7108-11. PubMed ID: 25813715
[TBL] [Abstract][Full Text] [Related]
13. Carbonic anhydrase inhibitors. Interaction of indapamide and related diuretics with 12 mammalian isozymes and X-ray crystallographic studies for the indapamide-isozyme II adduct.
Temperini C; Cecchi A; Scozzafava A; Supuran CT
Bioorg Med Chem Lett; 2008 Apr; 18(8):2567-73. PubMed ID: 18374572
[TBL] [Abstract][Full Text] [Related]
14. Carbonic anhydrase inhibitor coated gold nanoparticles selectively inhibit the tumor-associated isoform IX over the cytosolic isozymes I and II.
Stiti M; Cecchi A; Rami M; Abdaoui M; Barragan-Montero V; Scozzafava A; Guari Y; Winum JY; Supuran CT
J Am Chem Soc; 2008 Dec; 130(48):16130-1. PubMed ID: 18989963
[TBL] [Abstract][Full Text] [Related]
15. Carbonic anhydrase inhibitors: Inhibition of the new membrane-associated isoform XV with phenols.
Innocenti A; Hilvo M; Scozzafava A; Parkkila S; Supuran CT
Bioorg Med Chem Lett; 2008 Jun; 18(12):3593-6. PubMed ID: 18501600
[TBL] [Abstract][Full Text] [Related]
16. Carbonic anhydrases: novel therapeutic applications for inhibitors and activators.
Supuran CT
Nat Rev Drug Discov; 2008 Feb; 7(2):168-81. PubMed ID: 18167490
[TBL] [Abstract][Full Text] [Related]
17. Carbonic anhydrase inhibitors: inhibition of human cytosolic isozymes I and II and tumor-associated isozymes IX and XII with S-substituted 4-chloro-2-mercapto-5-methyl-benzenesulfonamides.
Saczewski F; Innocenti A; Sławiński J; Kornicka A; Brzozowski Z; Pomarnacka E; Scozzafava A; Temperini C; Supuran CT
Bioorg Med Chem; 2008 Apr; 16(7):3933-40. PubMed ID: 18242998
[TBL] [Abstract][Full Text] [Related]
18. Carbonic anhydrase: an efficient enzyme and an elusive mechanism.
Kumar V; Kannan KK
Indian J Biochem Biophys; 1994 Oct; 31(5):377-86. PubMed ID: 7851937
[No Abstract] [Full Text] [Related]
19. S-glycosyl primary sulfonamides--a new structural class for selective inhibition of cancer-associated carbonic anhydrases.
Lopez M; Paul B; Hofmann A; Morizzi J; Wu QK; Charman SA; Innocenti A; Vullo D; Supuran CT; Poulsen SA
J Med Chem; 2009 Oct; 52(20):6421-32. PubMed ID: 19827837
[TBL] [Abstract][Full Text] [Related]
20. Synthesis of alpha-fluoro- and alpha,alpha-difluoro-benzenemethanesulfonamides: new inhibitors of carbonic anhydrase.
Blackburn GM; Türkmen H
Org Biomol Chem; 2005 Jan; 3(2):225-6. PubMed ID: 15632963
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
